These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 3103980)
1. A morphometric study of the effect of oral norethisterone or levonorgestrel on endometrial blood vessels. Hourihan HM; Sheppard BL; Bonnar J Contraception; 1986 Dec; 34(6):603-12. PubMed ID: 3103980 [TBL] [Abstract][Full Text] [Related]
2. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users. Wonodirekso S; Hadisaputra W; Affandi B; Siregar B; Rogers PA Hum Reprod; 1996 Oct; 11 Suppl 2():144-9. PubMed ID: 8982756 [TBL] [Abstract][Full Text] [Related]
3. Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study. Hickey M; Fraser I; Dwarte D; Graham S Hum Reprod; 1996 Oct; 11 Suppl 2():35-44. PubMed ID: 8982744 [TBL] [Abstract][Full Text] [Related]
5. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses. Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516 [TBL] [Abstract][Full Text] [Related]
6. Endometrial effects of levonorgestrel and estradiol: A Scanning electron microscopic study of the luminal epithelium. Nilsson O; Englund D; Weiner E; Victor A Contraception; 1980 Jul; 22(1):71-83. PubMed ID: 6774851 [TBL] [Abstract][Full Text] [Related]
7. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant). Marsh MM; Butt AR; Riley SC; Rogers PA; Susil B; Affandi B; Findlay JK; Salamonsen LA Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775 [TBL] [Abstract][Full Text] [Related]
8. Morphometric study of the human endometrium following continuous exposure to levonorgestrel released from vaginal rings during 90 days. Johannisson E; Brosens I; Cornillie F; Elder M; White J; Sheppard B; Hourihan H; d'Arcangues C; Belsey EM Contraception; 1991 Apr; 43(4):361-74. PubMed ID: 1906792 [TBL] [Abstract][Full Text] [Related]
9. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen. Wilson ES; Cruickshank J; McMaster M; Weir RJ Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589 [TBL] [Abstract][Full Text] [Related]
10. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel. Goodger AM; Rogers PA; Affandi B Hum Reprod; 1994 Sep; 9(9):1647-51. PubMed ID: 7530724 [TBL] [Abstract][Full Text] [Related]
11. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549 [TBL] [Abstract][Full Text] [Related]
13. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles. Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585 [TBL] [Abstract][Full Text] [Related]
14. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery. Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550 [TBL] [Abstract][Full Text] [Related]
15. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users. Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753 [TBL] [Abstract][Full Text] [Related]
16. Endometrial vascular features prior to and following exposure to levonorgestrel. Hourihan HM; Sheppard BL; Belsey EM; Brosens IA Contraception; 1991 Apr; 43(4):375-85. PubMed ID: 1906793 [TBL] [Abstract][Full Text] [Related]
17. Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol. Joshi UM; Joshi JV; Donde UM; Sankoli GM; Virkar KD; Saxena BN Contraception; 1985 Jan; 31(1):71-82. PubMed ID: 3921309 [TBL] [Abstract][Full Text] [Related]
18. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response. Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746 [TBL] [Abstract][Full Text] [Related]
19. Prostaglandin production in human endometrium following continuous exposure to low-dose levonorgestrel released from a vaginal ring. White JO; Sullivan MH; Patel L; Croxtall JD; d'Arcangues C; Belsey EM; Elder MG Contraception; 1991 Apr; 43(4):401-12. PubMed ID: 1649733 [TBL] [Abstract][Full Text] [Related]
20. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]